Singular Genomics Systems Inc
NASDAQ:OMIC
Singular Genomics Systems Inc
Cash from Investing Activities
Singular Genomics Systems Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
Cash from Investing Activities
$13.8m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Investing Activities
-$131.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Singular Genomics Systems Inc's Cash from Investing Activities?
Cash from Investing Activities
13.8m
USD
Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Cash from Investing Activities amounts to 13.8m USD.
What is Singular Genomics Systems Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-17%
The average annual Cash from Investing Activities growth rates for Singular Genomics Systems Inc have been -17% over the past three years .